BBI plans to raise the bar at this year's AACC event through the launch of its new hand held reader and Group end to end IVD assay development solution.
One of the first mobile readers available for the IVD market, BBI's Novarum Reader uses smartphone based software which can be developed to read any lateral flow test.
Compatible with most leading smartphones on the market today, the portable technology allows users to test in any location - providing instant access to quantified results, removing ambiguity and saving time and cost over lab based testing.
Mobile connectivity allows existing phones to be easily deployed as readers by downloading Novarum's patent protected image processing technology via app stores and Google Play.
Leigh Thomas, Head of Sales commented "Every lateral flow test is unique; Novarum is a bespoke service which when customised for your lateral flow test creates a hand held reader that provides specific and accurately quantified results in an instant. The connectivity of the reader is also revolutionary and separates this from existing platforms".
BBI is also inviting customers to join the company on a journey at this year's Annual Meeting. Through strategic investments including the acquisition of BBI Enzymes in 2007 and SCIPAC in 2010, BBI has created a portfolio of products and services which offer immunoassay manufacturers an end to end IVD assay development solution from initial concept through launch:
The Concept: Quality and regulatory requirements
Sourcing Reagents: Biologicals including antigens, antibodies and enzymes; nanoparticle labels and controls and positive samples
Development and Optimisation: Lateral flow test and the new Novarum Reader
Manufacture and Validation: Contract manufacture and machinery
AACC 2012 takes place in Los Angeles, California from the 17th to the 19th of July. Visitors will be able to find BBInternational, BBI Enzymes and SCIPAC in the South Hall, at booth 627.